Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment Update in Multiple Sclerosis.
Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Multiple sclerosis: Progression rate and severity in a multicenter cohort from Algeria.
[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Season of birth as a risk factor for multiple sclerosis in Brazil.
OLFACTORY ENSHEATHING GLIA CELL THERAPY AND TUBULAR CONDUIT ENHANCE NERVE REGENERATION AFTER MOUSE SCIATIC NERVE TRANSECTION.
Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.
Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients.
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.
Communication with patients suffering from serious physical illness.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Ocular inflammation in neurorheumatic disease.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Evaluation of new immunological targets in neuromyelitis optica.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.
Pages
« first
‹ previous
…
276
277
278
279
280
281
282
283
284
…
next ›
last »